top of page
TheraSonic
Is developing a revolutionary technology using non-invasive focused ultrasound to enhance drug delivery to the brain. By specifically targeting the blood-brain barrier (BBB), this approach makes it possible to cross this protective barrier and deliver therapeutic treatments to targeted areas of the brain, as in the case of primary tumours or brain metastases.
PSCC's entrance
Décembre 2025
Localization
FR - Île-de-France
Modality
DM
Development status
Medtech - Development
Lauréat (s)
iLAB
bottom of page



